Enhanced Pro-apoptotic Effects of Fe(II)-Modified IVIG on Human Neutrophils.
Options
BORIS DOI
Date of Publication
2020
Publication Type
Article
Division/Institute
Contributor
Schneider, Christoph | |
Verschoor, Daniëlle | |
von Däniken, Sandro Urs | |
Seibold, Frank | |
Yawalkar, Nikhil | Universitätsklinik für Dermatologie |
Dimitrov, Jordan D | |
Smith, David F | |
Cummings, Richard D | |
Vassilev, Tchavdar |
Subject(s)
Series
Frontiers in immunology
ISSN or ISBN (if monograph)
1664-3224
Publisher
Frontiers Research Foundation
Language
English
Publisher DOI
PubMed ID
32508840
Uncontrolled Keywords
Description
Mild modification of intravenous immunoglobulin (IVIG) has been reported to result in enhanced polyspecificity and leveraged therapeutic effects in animal models of inflammation. Here, we observed that IVIG modification by ferrous ions, heme or low pH exposure, shifted the repertoires of specificities in different directions. Ferrous ions exposed Fe(II)-IVIG, but not heme or low pH exposed IVIG, showed increased pro-apoptotic effects on neutrophil granulocytes that relied on a FAS-dependent mechanism. These effects were also observed in human neutrophils primed by inflammatory mediators or rheumatoid arthritis joint fluid in vitro, or patient neutrophils ex vivo from acute Crohn's disease. These observations indicate that IVIG-mediated effects on cells can be enhanced by IVIG modification, yet specific modification conditions may be required to target specific molecular pathways and eventually to enhance the therapeutic potential.
File(s)
File | File Type | Format | Size | License | Publisher/Copright statement | Content | |
---|---|---|---|---|---|---|---|
Von Gunten_Enhanced Pro-apoptotic Effects.pdf | text | Adobe PDF | 1.16 MB | published |